The modeling of multicancer early detection (MCED) tests' residual risk and the challenges of MCED evaluation and implementation
Cancer
.
2023 Jul 1;129(13):1966-1968.
doi: 10.1002/cncr.34745.
Epub 2023 Mar 21.
Authors
Larry Kessler
1
,
Michelle M Le Beau
2
3
,
Robert A Smith
4
,
Fiona M Walter
5
6
,
Richard Wender
7
Affiliations
1
Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, Washington, USA.
2
Medicine-Hematology/Oncology, University of Chicago, Chicago, Illinois, USA.
3
Cancer Prevention & Research Institute of Texas, Austin, Texas, USA.
4
Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia, USA.
5
Wolfson Institute of Population Health, London, UK.
6
Primary Care Cancer Research, Queen Mary University of London, London, UK.
7
Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
PMID:
36943845
DOI:
10.1002/cncr.34745
No abstract available
Publication types
Editorial
Comment
MeSH terms
Early Detection of Cancer
Early Diagnosis
Humans
Neoplasms* / diagnosis
Neoplasms* / epidemiology